Watch Demo

Preclinical Imaging Market Research Report by Product, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Preclinical Imaging Market Research Report by Product, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:156

  • Report ID:6405090

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Preclinical Imaging Market Research Report by Product (Modalities and Reagents), Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

The United States Preclinical Imaging Market size was estimated at USD 508.83 million in 2022 and expected to reach USD 554.50 million in 2023, projecting growth at a CAGR of 7.15% to reach USD 884.23 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Preclinical Imaging Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Preclinical Imaging Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Preclinical Imaging Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Preclinical Imaging Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Preclinical Imaging Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market is studied across Modalities and Reagents. The Modalities is further studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-Computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-Photon Emission Computed Tomography. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents.

Based on Application, the market is studied across Drug Discovery and Research & Development.

Based on End-User, the market is studied across Biotech Companies, Pharmaceutical Companies, and Research Institutes.

Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Preclinical Imaging Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Preclinical Imaging Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Preclinical Imaging Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Preclinical Imaging Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Preclinical Imaging Market, including Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, FUJIFILM Holdings America Corporation, General Electric Company, INDEC BioSystems, KUBTEC Technology, LI-COR, Inc., Mediso Ltd., MILabs B.V, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, Scitech Pty Ltd., and Siemens A.G.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Preclinical Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Preclinical Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Preclinical Imaging Market?
4. What is the competitive strategic window for opportunities in the United States Preclinical Imaging Market?
5. What are the technology trends and regulatory frameworks in the United States Preclinical Imaging Market?
6. What is the market share of the leading vendors in the United States Preclinical Imaging Market?
7. What modes and strategic moves are considered suitable for entering the United States Preclinical Imaging Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adaptation of diagnostic imaging
5.1.1.2. Rising demand for non-invasive diagnostics and therapeutic devices
5.1.2. Restraints
5.1.2.1. Lack of reimbursement coverage
5.1.3. Opportunities
5.1.3.1. Technological advancements in molecular imaging
5.1.4. Challenges
5.1.4.1. Limitations of preclinical imaging
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Preclinical Imaging Market, by Product
6.1. Introduction
6.2. Modalities
6.3.1. Magnetic Particle Imaging
6.3.2. Magnetic Resonance Imaging
6.3.3. Micro-Computed Tomography
6.3.4. Optical Imaging
6.3.5. Positron Emission Tomography
6.3.6. Single-Photon Emission Computed Tomography
6.3. Reagents
6.4.1. Bioluminescent Imaging Reagents
6.4.2. Fluorescent Imaging Reagents
6.4.3. MRI Contrasting Reagents
6.4.4. PET Radioactive Tracers
6.4.5. Ultrasound Contrasting Reagents
6.4.6. X-ray CT Contrasting Reagents

7. Preclinical Imaging Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Research & Development

8. Preclinical Imaging Market, by End-User
8.1. Introduction
8.2. Biotech Companies
8.3. Pharmaceutical Companies
8.4. Research Institutes

9. California Preclinical Imaging Market
9.1. Introduction

10. Florida Preclinical Imaging Market
10.1. Introduction

11. Illinois Preclinical Imaging Market
11.1. Introduction

12. New York Preclinical Imaging Market
12.1. Introduction

13. Ohio Preclinical Imaging Market
13.1. Introduction

14. Pennsylvania Preclinical Imaging Market
14.1. Introduction

15. Texas Preclinical Imaging Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Angstrom Advanced Inc.
17.2. Aspect Imaging Ltd.
17.3. Berthold Technologies
17.4. Bruker Corporation
17.5. FUJIFILM Holdings America Corporation
17.6. General Electric Company
17.7. INDEC BioSystems
17.8. KUBTEC Technology
17.9. LI-COR, Inc.
17.10. Mediso Ltd.
17.11. MILabs B.V
17.12. Miltenyi Biotec GmbH
17.13. MR Solutions Group
17.14. Peira bvba
17.15. Scitech Pty Ltd.
17.16. Siemens A.G

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES PRECLINICAL IMAGING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES PRECLINICAL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES PRECLINICAL IMAGING MARKET DYNAMICS
FIGURE 8. UNITED STATES PRECLINICAL IMAGING MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES PRECLINICAL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 27. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 28. UNITED STATES PRECLINICAL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 29. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 32. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 33. UNITED STATES PRECLINICAL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 34. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 37. CALIFORNIA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. FLORIDA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. ILLINOIS PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. NEW YORK PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. OHIO PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. PENNSYLVANIA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. TEXAS PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES PRECLINICAL IMAGING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 45. UNITED STATES PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 46. UNITED STATES PRECLINICAL IMAGING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. UNITED STATES PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY BIOTECH COMPANIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CALIFORNIA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. CALIFORNIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CALIFORNIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CALIFORNIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. FLORIDA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 51. FLORIDA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. FLORIDA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ILLINOIS PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. ILLINOIS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. NEW YORK PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. NEW YORK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. OHIO PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 63. OHIO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. OHIO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. OHIO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. PENNSYLVANIA PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. PENNSYLVANIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. PENNSYLVANIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. PENNSYLVANIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. TEXAS PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 71. TEXAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. TEXAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. TEXAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PRECLINICAL IMAGING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 75. UNITED STATES PRECLINICAL IMAGING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 76. UNITED STATES PRECLINICAL IMAGING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 77. UNITED STATES PRECLINICAL IMAGING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 78. UNITED STATES PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 79. UNITED STATES PRECLINICAL IMAGING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 80. UNITED STATES PRECLINICAL IMAGING MARKET MERGER & ACQUISITION
TABLE 81. UNITED STATES PRECLINICAL IMAGING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. UNITED STATES PRECLINICAL IMAGING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. UNITED STATES PRECLINICAL IMAGING MARKET INVESTMENT & FUNDING
TABLE 84. UNITED STATES PRECLINICAL IMAGING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 85. UNITED STATES PRECLINICAL IMAGING MARKET: LICENSE & PRICING

Companies Mentioned

Angstrom Advanced Inc.
Aspect Imaging Ltd.
Berthold Technologies
Bruker Corporation
FUJIFILM Holdings America Corporation
General Electric Company
INDEC BioSystems
KUBTEC Technology
LI-COR, Inc.
Mediso Ltd.
MILabs B.V
Miltenyi Biotec GmbH
MR Solutions Group
Peira bvba
Scitech Pty Ltd.
Siemens A.G

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.